|Awarded On||August 21, 2019|
|Title||Patient-centered liver cancer prevention in the Houston community|
|Award Mechanism||Collaborative Action Program to Reduce Liver Cancer Mortality in Texas: Investigator-Initiated Research Awards|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Jessica Hwang|
|Cancer Sites||Gallbladder, Liver and Intrahepatic Bile Duct|
*Pending contract negotiation
There are medical conditions that increase a person’s risk of developing liver cancer, and these risk factors include hepatitis B and C virus infections, alcohol liver disease, and non-alcoholic fatty liver disease. People at risk for liver cancer can have none, one, or more than one of the risk factors. These risk factors can lead to fibrosis (potentially reversible) and subsequent cirrhosis (irreversible) of the liver, which in turn can lead to liver cancer. Current recommendation by medical groups is to screen adult patients seeking primary care suspected to have risk factors, such as hepatitis or alcohol use disorder, one risk factor at a time, but screening rates are low. Due to lack of...